Patent · US Active

Viral antigens

US11266733B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Wivine Burny · Rixensart, BE
Cindy Castado · Rixensart, BE
Sandra Giannini · Rixensart, BE
Julien Thierry Massaux · Rixensart, BE

Key dates

Filing date	Sep 25, 2018
Grant date	Mar 8, 2022
Priority date	—
Expiry date	Sep 25, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/36143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleotide constructs encoding antigenic peptides or polypeptides derived from multiple Human Papilloma Virus (HPV) early proteins, immunogenic compositions comprising such constructs and a pharmaceutically acceptable carrier, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.